Zhitong Finance App News, Shiyao Group (01093.HK) issued an announcement regarding the Group's signing of a strategic research and development cooperation agreement (this agreement) with AstraZeneca to discover and develop novel oral small molecule drug candidates. Unless otherwise defined, the terms used in this Notice have the same meaning as those defined in this Notice.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.